Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001168:Arthritis / Q000139:chemically induced / Q000517:prevention & control; D001835:Body Weight / Q000187:drug effects; D015519:Bone Density / Q000187:drug effects; D002351:Carrageenan; D004305:Dose-Response Relationship, Drug; D005122:Exudates and Transudates / Q000187:drug effects; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D066298:In Vitro Techniques; D007213:Indomethacin; D008297:Male; D010894:Piroxicam / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors; D010998:Pleurisy / Q000139:chemically induced / Q000517:prevention & control; D011758:Pyrroles / Q000494:pharmacology*; D051381:Rats; D013929:Thromboxane B2 / Q000097:blood